Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This reflects a backend page revision update rather than any change to study data or content.
    Difference
    0.1%
    Check dated 2026-05-15T23:44:20.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    No textual changes were captured in the provided data. The page content remains as published, with no additions or deletions recorded.
    Difference
    0.1%
    Check dated 2026-05-01T21:47:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer’s revision/build version was updated from v3.5.2 to v3.5.3, reflecting a platform change rather than any change to the clinical trial’s content.
    Difference
    0.1%
    Check dated 2026-04-24T16:44:44.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:31:25.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Medullary thyroid carcinoma as a disease reference. Included the Genetic and Rare Diseases Information Center as a Resources entry.
    Difference
    0.2%
    Check dated 2026-04-03T05:15:53.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:19:55.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.